ask="0.162"
ask_size="900"
average_daily_volume="1286320"
bid="0.162"
bid_size="300"
book_value="0.073"
change="-0.001"
change_from_200_day_moving_average="-0.054"
change_from_50_day_moving_average="-0.001"
change_from_52_week_high="-0.266"
change_From_52_week_low="0.031"
change_in_percent="-0.629%"
close="0.158"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.057"
ebitda="-16.83M"
eps_estimate_current_year="-0.070"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.100"
ex_dividend_date="N/A"
float_shares="215606000"
high="0.164"
high_52_weeks="0.424"
last_trade_date="1/6/2017"
last_trade_price="0.158"
last_trade_size="100"
last_trade_time="4:02pm"
low="0.158"
low_52_weeks="0.127"
market_capitalization="37.50M"
moving_average_200_day="0.212"
moving_average_50_day="0.159"
name="Rexahn Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.500"
open="0.160"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-25.527%"
percent_change_from_50_day_moving_average="-0.875%"
percent_change_from_52_week_high="-62.780%"
percent_change_from_52_week_low="+24.409%"
previous_close="0.159"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.178"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="2.480"
stock_exchange="ASE"
symbol="RNN"
volume="1034434"
weeks_range_52="0.127 - 0.424"
